M&A Deal Summary

Opko Acquires Transition Therapeutics

On June 30, 2016, Opko acquired life science company Transition Therapeutics for 60M USD

Acquisition Highlights
  • This is Opko’s 8th transaction in the Life Science sector.
  • This is Opko’s 4th largest (disclosed) transaction.
  • This is Opko’s 3rd transaction in Canada.
  • This is Opko’s 3rd transaction in Ontario.

M&A Deal Summary
Date 2016-06-30
Target Transition Therapeutics
Sector Life Science
Buyer(s) Opko
Deal Type Add-on Acquisition
Deal Value 60M USD

Target

Transition Therapeutics

Toronto, Ontario, Canada
Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, Ontario.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Opko

Miami, Florida, United States
Category Company
Founded 1991
Sector Life Science
Employees3,930
Revenue 863M USD (2023)
DESCRIPTION
Opko's corporate headquarters in Miami, Florida.
Opko's corporate headquarters in Miami, Florida.

Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.

DEAL STATS #
Overall 19 of 20
Sector (Life Science) 8 of 9
Type (Add-on Acquisition) 17 of 18
State (Ontario) 3 of 3
Country (Canada) 3 of 3
Year (2016) 1 of 1
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-20 Bio-Reference Laboratories

Elmwood Park, New Jersey, United States

Bio-Reference Laboratories, Inc. is a full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions.

Buy $1.5B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-17 CareEvolve

Elmwood Park, New Jersey, United States

CareEvolve is a provider of internet based order entry and results reporting solutions for laboratory, pathology and radiology outreach businesses.

Sell -
Mergr

Product

Company

Legal